» Articles » PMID: 22687278

The Montreal Cognitive Assessment is Superior to the Mini-Mental State Examination in Detecting Patients at Higher Risk of Dementia

Overview
Publisher Elsevier
Specialties Geriatrics
Psychiatry
Date 2012 Jun 13
PMID 22687278
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To examine the discriminant validity of the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE) in detecting patients with cognitive impairment at higher risk for dementia at a memory clinic setting.

Methods: Memory clinic patients were administered the MoCA, MMSE, and a comprehensive formal neuropsychological battery. Mild cognitive impairment (MCI) subtypes were dichotomized into two groups: single domain-MCI (sd-MCI) and multiple domain-MCI (md-MCI). Area under the receiver operating characteristic curve (ROC) analysis was used to compare the discriminatory ability of the MoCA and the MMSE.

Results: Two hundred thirty patients were recruited, of which 136 (59.1%) were diagnosed with dementia, 61 (26.5%) with MCI, and 33 (14.3%) with no cognitive impairment (NCI). The majority of MCI patients had md-MCI (n = 36, 59%). The MoCA had significantly larger AUCs than the MMSE in discriminating md-MCI from the lower risk group for incident dementia (NCI and sd-MCI) [MoCA 0.92 (95% CI, 0.86-0.98) vs. MMSE 0.84 (95% CI, 0.75-0.92), p = 0.02). At their optimal cut-off points, the MoCA (19/20) remained superior to the MMSE (23/24) in detecting md-MCI [sensitivity: 0.83 vs. 0.72; specificity: 0.86 vs. 0.83; PPV: 0.79 vs. 0.72; NPV: 0.89 vs. 0.83; correctly classified: 85.1% vs. 78.7%].

Conclusion: The MoCA is superior to the MMSE in the detection of patients with cognitive impairment at higher risk for incident dementia at a memory clinic setting.

Citing Articles

Noise exposure, hearing loss and cognitive impairment: a cross-sectional study based on an occupational health surveillance cohort in China.

Huang L, Li L, Wang J, Zhang S, Wu H, Lan Y Front Public Health. 2025; 13:1455340.

PMID: 40046130 PMC: 11880209. DOI: 10.3389/fpubh.2025.1455340.


A study of the correlation between sarcopenia and cognitive impairment in older individuals over 60 years: cross-sectional and longitudinal validation.

Dong X, Yu Y, Li J, Chai X, Shan W, Yan H Front Aging Neurosci. 2024; 16:1489185.

PMID: 39665043 PMC: 11631896. DOI: 10.3389/fnagi.2024.1489185.


Comorbidities, medications, depression, and physical performance measures associated with severe cognitive impairments in community-dwelling adults.

Almutairi G, Almegbas N, Alosaimi R, Alqahtani M, Batook S, Alfageh I PLoS One. 2024; 19(9):e0309765.

PMID: 39298495 PMC: 11412537. DOI: 10.1371/journal.pone.0309765.


Air pollution: a latent key driving force of dementia.

Mohammadzadeh M, Khoshakhlagh A, Grafman J BMC Public Health. 2024; 24(1):2370.

PMID: 39223534 PMC: 11367863. DOI: 10.1186/s12889-024-19918-4.


On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.

Ilardi C, Menichelli A, Michelutti M, Cattaruzza T, Federico G, Salvatore M J Alzheimers Dis. 2024; 101(1):293-308.

PMID: 39150828 PMC: 11492110. DOI: 10.3233/JAD-240339.